![]() | Only 14 pages are availabe for public view |
Abstract Normo gonadotropic anovulation, also known as type II anovulation according to the World Health Organization(WHO) classification, is one of the main causes of infertility, with up to 90% of type II WHO an ovulatory patient affected by polycystic ovary syndrome (PCOS).Gonadotropin has been shown to be effective but requires expertise and carries high direct and indirect costs and a high risk of multiple ovulations,multiple pregnancy,and ovarian hyper stimulation syndrome (OHSS. |